Relapsed follicular B-cell non-Hodgkin lymphoma

Also known as: Relapsed follicular B-cell non-Hodgkin's lymphoma

Drug	Drug Name	Drug Description
DB00078	Ibritumomab tiuxetan	A monoclonal anti-CD20 antibody used to treat B-cell non-Hodgkin's lymphoma via a conjugated radioactive isotope.
DB09054	Idelalisib	An antineoplastic kinase inhibitor used to treat chronic lymphocytic leukemia (CLL), relapsed follicular B-cell non-Hodgkin lymphoma (FL), and relapsed small lymphocytic lymphoma (SLL).
DB00073	Rituximab	A monoclonal anti-CD20 antibody used to treat non-Hodgkin's lymphoma, chronic lymphocytic leukemia, Wegener's granulomatosis, pemphigus vulgaris, and rheumatoid arthritis.

Drug	Drug Name	Target	Type
DB00078	Ibritumomab tiuxetan	B-lymphocyte antigen CD20	target
DB09054	Idelalisib	Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit delta isoform	target
DB09054	Idelalisib	ATP-binding cassette sub-family G member 2	transporter
DB09054	Idelalisib	P-glycoprotein 1	transporter
DB09054	Idelalisib	Aldehyde oxidase	enzyme
DB09054	Idelalisib	Cytochrome P450 2C8	enzyme
DB09054	Idelalisib	Cytochrome P450 2C19	enzyme
DB09054	Idelalisib	Cytochrome P450 2B6	enzyme
DB09054	Idelalisib	Cytochrome P450 3A4	enzyme
DB09054	Idelalisib	Solute carrier organic anion transporter family member 1B1	transporter
DB09054	Idelalisib	Solute carrier organic anion transporter family member 1B3	transporter
DB09054	Idelalisib	Cytochrome P450 3A5	enzyme
DB09054	Idelalisib	Cytochrome P450 3A43	enzyme
DB09054	Idelalisib	Cytochrome P450 3A7	enzyme
DB09054	Idelalisib	UDP-glucuronosyltransferase 1-4	enzyme
DB00073	Rituximab	B-lymphocyte antigen CD20	target

Drug	Drug Name	Phase	Status	Count